@article{154876e123ac4bc1a893de2a1a324ec0,
title = "Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection",
abstract = "Background Cholera is a public health problem worldwide, and the risk factors for infection are only partially understood. Methods We prospectively studied household contacts of patients with cholera to compare those who were infected to those who were not. We constructed predictive machine learning models of susceptibility, using baseline gut microbiota data. We identified bacterial taxa associated with susceptibility to Vibrio cholerae infection and tested these taxa for interactions with V. cholerae in vitro. Results We found that machine learning models based on gut microbiota, as well as models based on known clinical and epidemiological risk factors, predicted V. cholerae infection. A predictive gut microbiota of roughly 100 bacterial taxa discriminated between contacts who developed infection and those who did not. Susceptibility to cholera was associated with depleted levels of microbes from the phylum Bacteroidetes. By contrast, a microbe associated with cholera by our modeling framework, Paracoccus aminovorans, promoted the in vitro growth of V. cholerae. Gut microbiota structure, clinical outcome, and age were also linked. Conclusion These findings support the hypothesis that abnormal gut microbial communities are a host factor related to V. cholerae susceptibility.",
author = "Midani, {Firas S.} and Weil, {Ana A.} and Fahima Chowdhury and Begum, {Yasmin A.} and Khan, {Ashraful I.} and Debela, {Meti D.} and Durand, {Heather K.} and Reese, {Aspen T.} and Nimmagadda, {Sai N.} and Silverman, {Justin D.} and Ellis, {Crystal N.} and Ryan, {Edward T.} and Calderwood, {Stephen B.} and Harris, {Jason B.} and Firdausi Qadri and David, {Lawrence A.} and Larocque, {Regina C.}",
note = "Funding Information: Financial support. This work was supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH; grants R01AI103055 [to J. B. H. and R. C. L.], U01AI0589354 [to E. T. R. and S. B. C.], and T32A1070611976 and K08AI123494 [to A. A. W.]); the National Institute of General Medical Sciences, NIH (grants T32GM071340 [to F. S. M.] and T32GM007171 [to J. D. S.]); the NSF (grants DGE-1545220 [to F.S.M.] and DGE-1106401 [to A. T. R.]); the Searle Scholars Program (to L. A. D.); the Alfred P. Sloan Foundation (research fellowship to L. A. D.); the North Carolina Biotechnology Center (grant 2016-IDG-1013 [HARDAC+: Reproducible HPC for Next-generation Genomics]); the Government of the People{\textquoteright}s Republic of Bangladesh (to the International Centre for Diarrhoeal Disease Research [icddr,b]); Global Affairs Canada (to the icddr,b); the Swedish International Development Cooperation Agency (to the icddr,b); and the UK Department for International Development (to the icddr,b). Publisher Copyright: {\textcopyright} The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.",
year = "2018",
month = jul,
day = "13",
doi = "10.1093/infdis/jiy192",
language = "English (US)",
volume = "218",
pages = "645--653",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",
}